A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines

Journal of Cancer Research and Clinical Oncology

Volumn 123, Issue 2, 1997, Pages 91-99

  Chang, Meng Yao ^a   Won, Shen Jeu ^a   Liu, Hsiao Sheng ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Ha ras oncogene; ribozyme; transformation; tumorigenicity

Indexed keywords

RIBOZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CELL TRANSFORMATION; CONTROLLED STUDY; GENETIC TRANSFECTION; MALE; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION; GENES, RAS; MALE; MICE; MICE, INBRED BALB C; MICE, SCID; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS P21(RAS); RNA, CATALYTIC;

EID: 0031046717     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01269886     Document Type: Article

References (36)

1. Altman S (1993) RNA enzyme-directed gene therapy. Proc Natl Acad Sci USA 90:10898-10900
2. Barbacid M (1987) Ras genes. Annu Rev Biochem 56:779-827
3. Barinaga M (1993) Ribozymes: killing the messenger. Science 262: 1512-1514
4. Berners-Price SJ, Mirabelli CK, Johnson RK, Mattern MR, McCabe FL, Faucette LF, Chiu MS, Shau MM, Sadler PJ, Crooke ST (1986) In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane] gold(I) chloride. Cancer Res 46:5486-5493
5. Bos JL (1989) Ras oncogenes in human cancer: a review. Cancer Res 49:4682-4689
6. Cantor GH, McElwain TF, Birkebak TA, Palmer GH (1993) Ribozyme cleaves rex/tax mRNA and inhibits bovine leukemia virus expression. Proc Natl Acad Sci USA 90:10932-10936
7. Cech TR (1988) Ribozymes and their medical implications. JAMA 260:3030-3034
8. Chatterjee S, Johnson PR, Wong KK (1992) Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector. Science 258:1485-1488
9. Feng M, Cabrera G, Deshane J, Scanlon KJ, Curiel DT (1995) Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Res 55: 2024-2028
10. Fort LM, Piechaczyk M, Sabrouty SE, Dani C, Jeanteur P, Blanchard JM (1985) Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphatedehydrogenase multigenic family. Nucleic Acids Res 13: 1433-1442
11. Funato T, Shitara T, Tone T, Jiao L, Kashani-Sabet M, Scanlon KJ (1994) Suppression of Ha-ras-mediated transformation in NIH3T3 cells by a ras ribozyme. Biochem Pharmacol 48: 1471-1475
12. Ito M (1984) Microassay for studying anticellular effects of human interferons. J Interferon Res 4:603-608
13. Jones KA, Yamamoto KR, Tjian R (1985) Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell 42:559-572
14. Kashani-Sabet M, Funato T, Tone T, Jiao L, Wang W, Yoshida E, Kashfinn BI, Shitara T, Wu AM, Moreno JG, Traweek ST, Ahlering TE, Scanlon KJ (1992) Reversal of the malignant phenotype by an anti-ras ribozyme. Antisense Res Dev 2: 3-15
15. Kashani-Sabet M, Funato T, Florenes VA, Fodstad O, Scanlon KJ (1994) Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme. Cancer Res 54:900-902
16. Koizumi M, Kamiya H, Ohtsuka E (1992) Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene. Gene 117:179-184
17. Koizumi M, Kamiya H, Ohtsuka E (1993) Inhibition of the c-Ha-ras by hammerhead ribozymes containing a stable C(UUCG)G hairpin loop. Biol Pharm Bull 16:879-883
18. Kyprianou N, Isaacs JT (1990) Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene. Cancer Res 50: 1449-1454
19. Lieber A, Strauss M (1995) Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol Cell Biol 15:540-551
20. Liu HS, Scrable H, Villaret DB, Lieberman MA, Strambrook PJ (1992) Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements. Cancer Res 52:983-989
21. Lowy DR (1993) Function and regulation of ras. Annu Rev Biochem 62:851-891
22. Morgan RA, Anderson WF (1993) Human gene therapy. Annu Rev Biochem 62:191-217
23. Nabel GJ, Fox BA, Post L, Thompson CB, Woffendin C (1994) A molecular genetic intervention for AIDS: effects of a transdominant negative form of Rev. Hum Gene Ther 5:79-92
24. Poeschla E, Wong-Staal F (1994) Antiviral and anticancer ribozymes. Curr Opin Oncol 6: 601-606
25. Prendergast GC, Gibbs JB (1994) Ras regulatory interactions: novel targets for anticancer intervention? Bioessays 16:187-191
26. Renneisen K Leserman L, Mattes E, Schroder HC, Muller WE (1990) Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody targeted liposomes containing antisense RNA to the env region. J Biol Chem 265: 16337-16342
27. Rossi JJ (1995) Controlled, targeted, intracellular expression of ribozymes: progress and problems. Trends Biotechnol 13:301-306
28. Scanlon KJ, Jiao L, Funato T, Wang W, Tone T, Rossi JJ, Kashani-Sabet M (1991) Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Proc Natl Acad Sci USA 88:10591-10595
29. Shore SK, Nabissa PM, Reddy EP (1993) Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of p210 protein-kinase activity. Oncogene 8:3183-3188
30. Snyder DS, Wu Y, Wang JL, Rossi JJ, Swiderski P, Kaplan BE, Forman SJ (1993) Ribozyme mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line. Blood 82:600-605
31. Sullenger BA, Cech TR (1993) Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. Science 262:1566-1569
32. Sun LQ, Wang L, Gerlach WL, Symonds G (1995) Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA. Nucleic Acids Res 23:2909-2913
33. Tabin CJ, Bradley SM, Bargmann CI, Weinberg RA, Papageorge AG, Scolnick EM, Dhar R, Lowy DR, Chang EH (1982) Mechanisms of activation of a human oncogene. Nature 300: 143-149
34. Von Weizsacker F, Blum HE, Wands JR (1992) Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template. Biochem Biophys Res Commun 189:743-748
35. Wright L, Wilson SB, Milliken S, Biggs J, Kearney P (1993) Ribozyme-mediated cleavage of the bcr-abl transcript expressed in chronic myeloid leukemia. Exp Hematol 21:1714-1718
36. Yamada O, Yu M, Yee JK, Kraus G, Looney D, Wong-Staal F (1994) Intracellular immunization of human T-cells with a hairpin ribozyme against human immunodeficiency virus type I. Gene Ther 1:38-45